Dynamic Advisor Solutions LLC Has $2.54 Million Stock Holdings in CVS Health Corporation $CVS

Dynamic Advisor Solutions LLC trimmed its position in CVS Health Corporation (NYSE:CVS) by 0.6% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 36,795 shares of the pharmacy operator’s stock after selling 218 shares during the quarter. Dynamic Advisor Solutions LLC’s holdings in CVS Health were worth $2,538,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Woodline Partners LP acquired a new stake in CVS Health in the fourth quarter valued at approximately $2,451,000. Waverly Advisors LLC grew its position in CVS Health by 7.9% in the 4th quarter. Waverly Advisors LLC now owns 19,071 shares of the pharmacy operator’s stock valued at $856,000 after purchasing an additional 1,392 shares during the period. Novem Group acquired a new position in shares of CVS Health during the fourth quarter valued at about $562,000. McIlrath & Eck LLC grew its holdings in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 174 shares during the last quarter. Finally, Orion Capital Management LLC acquired a new position in shares of CVS Health during the fourth quarter valued at about $54,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

NYSE CVS opened at $74.40 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $75.55. The stock has a market capitalization of $94.37 billion, a PE ratio of 20.78, a P/E/G ratio of 0.82 and a beta of 0.62. The company’s 50 day simple moving average is $67.70 and its two-hundred day simple moving average is $66.55.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter last year, the business posted $1.83 earnings per share. The firm’s revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.6%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is currently 74.30%.

Analysts Set New Price Targets

CVS has been the topic of a number of analyst reports. Morgan Stanley lifted their price objective on shares of CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. UBS Group upgraded shares of CVS Health from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $67.00 to $79.00 in a report on Monday, August 18th. Sanford C. Bernstein boosted their price target on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a report on Friday, September 5th. Cowen restated a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $78.00 target price on shares of CVS Health in a research note on Tuesday, August 26th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $77.89.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the sale, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.22% of the stock is owned by corporate insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.